7,648.75

+34.75

+0.46%

52,174.00

+256.00

+0.49%

28,751.75

+217.75

+0.76%

Russell 2000 Futures

2,840.10

+18.80

+0.67%

4.9290

-0.0600

-1.20%

19.09

-0.33

-1.70%

3,910.30

+11.40

+0.29%

77,897.79

+149.35

+0.19%

Crude Oil Dec 26

99.68

-4.44

-4.26%

US Private Equity

10,850.63

-82.20

-0.75%

OTC Markets OTCPK - Delayed Quote USD

AB Science S.A. (ABSCF)

1.1200 0.0000 (0.00%)

At close: October 30 at 5:00:00 PM EDT

Loading Chart for ABSCF

Chart Range Bar

Interval:

In partnership with ChartIQ

AB Science will hold a web conference on Wednesday, October 14, 2026, from 6:00 p.m. to 7:30 p.m.

AB Science will hold a web conference on Wednesday, October 14, 2026, from 6:00 p.m. to 7:30 p.m.

AB Science today reports its revenues for the first half of 2026 and provides an update on its activities

AB Science today reports its revenues for the first half of 2026 and provides an update on its activities

AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection

AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection

AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026

AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026

AB Science announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million

AB Science announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million

The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight

The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight

Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Mobilize your Website

View Site in Mobile | Classic

Share by: